51. Scleroderma
466 clinical trials,   536 drugs   (DrugBank: 142 drugs),   110 drug target genes,   210 drug target pathways

Searched query = "Scleroderma", "Systemic sclerosis", "SSc", "dcSSc", "lcSSc"
The queries were searched in Public_title, Scientific_title, and Condition. Export date: 03/15/2021. Trials are sorted by Date_enrollment from most recent to oldest in the table.

Search in Page e.g. "Phase 3", "Not recruiting", "Japan"
1 trial found
No.TrialIDDate_
enrollment
Date_
registration
Public_titleScientific_titleConditionInterventionPrimary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
PhaseCountries
1EUCTR2004-002799-41-GB
(EUCTR)
15/08/200729/06/2005Iontophoresis as a possible therapy for digital ischaemia - preliminary studies in patients with scleroderma spectrum disorders - Vasodilator iontophoresis as a possible therapy for digital ischaemiaIontophoresis as a possible therapy for digital ischaemia - preliminary studies in patients with scleroderma spectrum disorders - Vasodilator iontophoresis as a possible therapy for digital ischaemia Digital ischaemia/ulceration in patients with scleroderma-spectrum disordersTrade Name: NON PROPIETRY, THEREFORE N/A
Product Name: SODIUM NITROPRUSSIDE
Salford Royal Hospitals TrustUNIVERSITY OF MANCHESTERNot RecruitingFemale: yes
Male: yes
6Phase 2United Kingdom